#VisualAbstract: Nirmatrelvir associated with improved COVID-19 outcomes in older adults
1. Older adults treated with nirmatrelvir were significantly less likely to be hospitalized for...
Read MoreSep 9, 2022
1. Older adults treated with nirmatrelvir were significantly less likely to be hospitalized for...
Read MoreSep 9, 2022
1. In this random1. In this randomized controlled trial that included 9711 patients...
Read MoreSep 6, 2022
Click here to read this study in NEJM.
Read MoreSep 6, 2022
Click here to read this study in JAMA.
Read MoreAug 27, 2022
Click here to read this study in NEJM.
Read MoreAug 24, 2022
1. In a group of patients undergoing endoscopic removal of symptomatic kidney stones, concurrent...
Read MoreAug 24, 2022
Click to read this study in JAMA.
Read MoreAug 19, 2022
1. Dulaglutide significantly reduced baseline glycated hemoglobin levels as compared to a placebo...
Read MoreAug 19, 2022
Click here to read this study in JAMA.
Read MoreAug 18, 2022
1. Prasinezumab had no meaningful effect on global or imaging measures of Parkinson’s disease...
Read MoreAug 18, 2022
Click here to read this study in JAMA.
Read MoreAug 16, 2022
Click to read this study in The Lancet Oncology.
Read MoreAug 13, 2022
Click here to read this study in JAMA.
Read MoreAug 11, 2022
1. In this secondary analysis of the DECLARE-TIMI 58 trial, among 17,160 patients, dapagliflozin...
Read MoreAug 11, 2022
Click to read this study in the Journal of Clinical Oncology.
Read MoreAug 11, 2022
1. Eszopiclone and Lemborexant were more efficacious for acute and long-term insomnia compared to...
Read MoreAug 10, 2022
Click to read this study in JAMA Oncology.
Read MoreAug 10, 2022
Click here to read this study in NEJM.
Read MoreAug 5, 2022
1. Fewer patients in the thrombectomy group achieved an MRS score of 0-2 at 90 days compared to...
Read MoreAug 5, 2022
Click to read this study in The Lancet Oncology.
Read More